Cariprazine

ATC N05AX15 · 6 markets · 23 records

Cariprazine 6 markets · 23 records Forms

US 6 records · 6 strengths

6 mgcapsuleVraylar also in GB·AU·ES
4.5 mgcapsuleVraylar also in GB·AU·ES
3 mgcapsuleVraylar also in GB·AU·ES
1.5 mgcapsuleVraylar also in GB·AU·ES
0.75 mgcapsuleVraylar
0.5 mgcapsuleVraylar

GB 4 records · 4 strengths

6 mgcapsuleReagila 1.5mg capsules also in US·AU·ES
4.5 mgcapsuleReagila 1.5mg capsules also in US·AU·ES
3 mgcapsuleReagila 1.5mg capsules also in US·AU·ES
1.5 mgcapsuleReagila 1.5mg capsules also in US·AU·ES

AU 4 records · 4 strengths

6 mgcapsuleReagila 1.5mg capsules also in US·GB·ES
4.5 mgcapsuleReagila 1.5mg capsules also in US·GB·ES
3 mgcapsuleReagila 1.5mg capsules also in US·GB·ES
1.5 mgcapsuleReagila 1.5mg capsules also in US·GB·ES

ES 4 records · 4 strengths

6 mgcapsuleReagila 1.5mg capsules also in US·GB·AU
4.5 mgcapsuleReagila 1.5mg capsules also in US·GB·AU
3 mgcapsuleReagila 1.5mg capsules also in US·GB·AU
1.5 mgcapsuleReagila 1.5mg capsules also in US·GB·AU

HK 4 records · 1 strengths

Records without a stated strength · 1 Reagila 1.5mg capsules

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 Reagila 1.5mg capsules

Side-by-side table

Strength / form / release	US	GB	AU	ES	HK	EU
6 mg capsule	Vraylar	Reagila 1.5mg capsules	Reagila 1.5mg capsules	Reagila 1.5mg capsules	not recorded	not recorded
4.5 mg capsule	Vraylar	Reagila 1.5mg capsules	Reagila 1.5mg capsules	Reagila 1.5mg capsules	not recorded	not recorded
3 mg capsule	Vraylar	Reagila 1.5mg capsules	Reagila 1.5mg capsules	Reagila 1.5mg capsules	not recorded	not recorded
1.5 mg capsule	Vraylar	Reagila 1.5mg capsules	Reagila 1.5mg capsules	Reagila 1.5mg capsules	not recorded	not recorded
0.75 mg capsule	Vraylar	not recorded	not recorded	not recorded	not recorded	not recorded
0.5 mg capsule	Vraylar	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	not recorded	Reagila 1.5mg capsules	Reagila 1.5mg capsules

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

1 more strength/form rows are recorded only in HK · EU and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en HK · EU que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 HK · EU 有记录（未在本表显示）。另有 1 個規格/劑型僅在 HK · EU 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.